| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Hexstone Capital LLC | 4.9% | -12% | $553,293 | +$169,293 | 216,130 | +44% | Hexstone Capital LLC | 31 Dec 2025 |
| Bleichroeder LP | 4.6% | -24% | $760,000 | 200,000 | 0% | Bleichroeder LP | 31 Dec 2025 | |
| INTRACOASTAL CAPITAL, LLC | 5% | 140,101 | Mitchell P. Kopin | 01 Jul 2025 | ||||
| LYTTON LAURENCE W | 1.6% | $250,788 | 51,391 | LYTTON LAURENCE W | 30 Jun 2025 | |||
| Nantahala Capital Management, LLC | 0.06% | $5,412 | 1,109 | Nantahala Capital Management, LLC | 30 Jun 2025 |
As of 31 Dec 2025, 19 institutional investors reported holding 336,454 shares of Cellectar Biosciences, Inc. - Common Shares (CLRB). This represents 7.8% of the company’s total 4,338,395 outstanding shares.